Camovis

Camovis

Munich, Germany· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Founded in 2018 and based in Munich, Camovis operates as a specialized service provider in the clinical research ecosystem, addressing critical resource gaps at trial sites. The company leverages a scalable network of over 350 pre-vetted research professionals to offer flexible, project-based support, reducing workload and increasing operational flexibility for its clients. With experience in over 260 clinical trials across more than 70 indications since 2014, Camovis has established a strong track record in traditional AMG/MPG studies and is expanding into the growing digital health applications sector. Its asset-light, service-oriented model positions it to capitalize on increasing clinical trial complexity and persistent site resourcing challenges.

Broad (70+ Indications)

Technology Platform

Operational platform for managing and deploying a network of over 350 'Flying Research Professionals' (Study Nurses, CRAs, Coordinators, etc.) to provide flexible, on-demand support for clinical trials.

Opportunities

The chronic shortage of skilled personnel at clinical trial sites and the increasing complexity of trials (e.g., decentralized trials, digital health apps, advanced therapies) create strong demand for flexible, expert support services.
Germany's established DiGA pathway presents a specific, high-growth niche for supporting digital health application trials.

Risk Factors

Quality control and consistency across a large, decentralized workforce is a major operational risk.
Competition from large CROs offering similar staffing solutions and local agencies could pressure margins.
The business is dependent on the health of the clinical trial market in the DACH region and is susceptible to client budget cuts.

Competitive Landscape

Camovis competes with the flexible staffing arms of large, global Contract Research Organizations (CROs) as well as regional and niche clinical staffing agencies. Its differentiation lies in its specialized focus on the DACH region, deep therapeutic area experience, and specific positioning in both traditional trials and the emerging digital health (DiGA/DiPA) space.